|
SMEK1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.083700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.571010E-01 |
| Normal-vs-Stage2 |
6.969900E-02 |
| Normal-vs-Stage3 |
5.816600E-04 |
| Normal-vs-Stage4 |
2.16459999999863E-05 |
| Stage1-vs-Stage2 |
2.778000E-01 |
| Stage1-vs-Stage3 |
1.704060E-02 |
| Stage1-vs-Stage4 |
5.412000E-04 |
| Stage2-vs-Stage3 |
5.518800E-01 |
| Stage2-vs-Stage4 |
2.133000E-01 |
| Stage3-vs-Stage4 |
3.353400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.482800E-03 |
| Normal-vs-AfricanAmerican |
1.156030E-01 |
| Normal-vs-Asian |
7.470800E-01 |
| Caucasian-vs-AfricanAmerican |
7.246000E-01 |
| Caucasian-vs-Asian |
2.855200E-01 |
| AfricanAmerican-vs-Asian |
3.787800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.375000E-04 |
| Normal-vs-Female |
1.778240E-01 |
| Male-vs-Female |
2.031700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.260250E-02 |
| Normal-vs-Age(41-60Yrs) |
6.787600E-02 |
| Normal-vs-Age(61-80Yrs) |
6.992300E-04 |
| Normal-vs-Age(81-100Yrs) |
5.342300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.183200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.873200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.717800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.132780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.670800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.576200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.596300E-02 |
| Normal-vs-Grade 2 |
5.646200E-01 |
| Normal-vs-Grade 3 |
2.16159999999466E-05 |
| Normal-vs-Grade 4 |
1.64849999984007E-07 |
| Grade 1-vs-Grade 2 |
7.025500E-02 |
| Grade 1-vs-Grade 3 |
2.171500E-04 |
| Grade 1-vs-Grade 4 |
1.73148000000012E-05 |
| Grade 2-vs-Grade 3 |
6.43699999999248E-05 |
| Grade 2-vs-Grade 4 |
5.00500000000237E-07 |
| Grade 3-vs-Grade 4 |
4.003600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.770000E-01 |
| Normal-vs-ccB subtype |
1.68805999999355E-05 |
| ccA subtype-vs-ccB subtype |
3.06650000003739E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.136000E-03 |
| Normal-vs-N1 |
1.50858999999892E-05 |
| N0-vs-N1 |
2.085800E-02 |
|
|
